Alamos Gold AGI 深 沪
交易中 08-19 11:36:28 美东时间
36.055
+3.155
+9.59%
华盛通- 最 高36.31
- 今 开34.76
- 成交量 206.85万股
- 最 低 34.535
- 昨 收 32.90
- 总市值 150.93亿
- 52周最高 55.33
- 市盈率 静 17.20
- 换手率 0.49%
- 52周最低 27.05
- 委 比 40.20%
- 总股本 4.19亿
- 历史最高 55.33
- 量 比 2.19
- 振 幅 5.40%
- 历史最低 1.525
- 每 手 1
- 风险率 6.45%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Stop Buying Gold Miners Until You Check This Metric
Valuing a gold mining stock goes beyond the surface metrics like the price-to-earnings ratio. An ounce is equal on a scale, but unequal when it comes to financial or operating risk. According to Kanz Terra Capital, one way to compare miners is to combine balance-sheet strength, production scale and ...
今天 18:41
$100 Invested In Alamos Gold 5 Years Ago Would Be Worth This Much Today
Alamos Gold (NYSE:AGI) has outperformed the market over the past 5 years by 22.09% on an annualized basis producing an average annual return of 33.74%. Currently, Alamos Gold has a market capitalization of $13.81 billion. Buying $100 In AGI: If an investor had bought $100 of AGI stock 5 years ago, i...
08-11 00:30
Alamos Gold Q2 Adj. EPS $0.59 Misses $0.70 Estimate, Sales $594.100M Miss $664.513M Estimate
Alamos Gold (NYSE:AGI) reported quarterly earnings of $0.59 per share which missed the analyst consensus estimate of $0.70 by 15.71 percent. This is a 73.53 percent increase over earnings of $0.34 per share from the same period last year. The company reported quarterly sales of $594.100 million whic...
07-30 05:16
美股大行评级 | 潜在涨幅246.92%！HC Wainwright & Co.上调Rockwell Medical(RMTI)目标价至20美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Rockwell Medical"买入"评级，目标价从2美元升至20美元；Canaccord Genuity：维持创力"买入"评级，目标价从10.5美元升至11美元
07-10 17:36
美股大行评级 | 高盛上调AMD目标价从450美元升至640美元；伯恩斯坦上调阿斯麦目标价从1971美元升至2623美元
今日重点评级关注：Roth Capital：维持Nuvectis Pharma"买入"评级，目标价从20美元升至33美元；摩根士丹利：维持GXO Logistics"超配"评级，目标价从75美元升至78美元
07-07 11:34
Jefferies Maintains Buy on Alamos Gold, Lowers Price Target to $49
Jefferies analyst Fahad Tariq maintains Alamos Gold (NYSE:AGI) with a Buy and lowers the price target from $50 to $49.
07-06 23:30
美股大行评级 | 阿斯麦获美银、富国上调目标价最高至2345美元；Needham上调美光科技目标价从500美元升至1550美元
今日重点评级关注：Baird：维持Regenxbio"跑赢大市"评级，目标价从27美元升至32美元；古根海姆：维持Tenax Therapeutics"买入"评级，目标价从34美元升至40美元
06-23 13:48
美股夜盘 | Apogee Therapeutics, Inc.涨21.45%，Definium Therapeutics, Inc.涨14.01%
Apogee Therapeutics, Inc.涨21.45%；Definium Therapeutics, Inc.涨14.01%；哥伦比亚银行涨8.04%
06-22 15:01
美股夜盘 | Apogee Therapeutics, Inc.涨21.45%，Definium Therapeutics, Inc.涨13.77%
Apogee Therapeutics, Inc.涨21.45%；Definium Therapeutics, Inc.涨13.77%；联电涨8.47%
06-22 13:01
